TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL PLANTAR FASCIITIS TREATMENT MARKET,BY TYPE
6.1. Overview
6.2. Medication Therapy
6.3. Oral
6.4. Parenteral
6.5. Orthotics
6.6. Shockwave Therapy
6.7. Surgery
6.8. Intracorporeal Pneumatic Shockwave Therapy
6.9. Others
7. GLOBAL PLANTAR FASCIITIS TREATMENT MARKET,BY TREATMENT TYPE
7.1. Overview
7.2. Pharmacological Treatment
7.3. Orthotic Devices
7.4. Shockwave Therapy
7.5. Surgery
7.6. Other Treatment Types
8. GLOBAL PLANTAR FASCIITIS TREATMENT MARKET,BY END-USER
8.1. Overview
8.2. Hospitals
8.3. Clinics
8.4. Others
9. GLOBAL PLANTAR FASCIITIS TREATMENT MARKET, BY REGION
9.1. Overview
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. France
9.2.3. UK
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. Australia
9.3.6. Rest of Asia-Pacific
9.4. Rest of the World
9.4.1. Middle East
9.4.2. Africa
9.4.3. Latin America
10. COMPETITIVE LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Plantar Fasciitis Treatment Market,
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Plantar Fasciitis Treatment Market,
10.7. Key developments and Growth Strategies
10.7.1. New ProductLaunch/Service Deployment
10.7.2. Merger &Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income,2022
10.8.2. Major Players R&D Expenditure.2022
11. COMPANY PROFILES
11.1. Bayer AG (Germany)
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Products Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. SUPERFEET WORLDWIDE, LLC (U.S.).
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Products Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Bauerfeind USA Inc. (Germany)
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Products Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Ottobock (Germany).
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Products Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Recover Sports Medicine (Australia).
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Products Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. Shapecrunch (India).
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Products Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. 3M (U.S.)
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Products Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. OrthoBethesda (U.S.)
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Products Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Apothecary Products, LLC (U.S.).
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Products Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Ellis & Badenhausen (U.S.).
11.10.1. Company Overview
11.10.2. Financial Overview
11.10.3. Products Offered
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
11.11. SYNXSOLE PTY LTD. (Australia)
11.11.1. Company Overview
11.11.2. Financial Overview
11.11.3. Products Offered
11.11.4. Key Developments
11.11.5. SWOT Analysis
11.11.6. Key Strategies
11.12. Revance Therapeutics, (U.S.)
11.12.1. Company Overview
11.12.2. Financial Overview
11.12.3. Products Offered
11.12.4. Key Developments
11.12.5. SWOT Analysis
11.12.6. Key Strategies
12. APPENDIX
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL PLANTAR FASCIITIS TREATMENT MARKET, SYNOPSIS, 2018-2032
TABLE 2 GLOBAL PLANTAR FASCIITIS TREATMENT MARKET, ESTIMATES &FORECAST, 2018-2032(USD BILLION)
TABLE 3 GLOBAL PLANTAR FASCIITIS TREATMENT MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL PLANTAR FASCIITIS TREATMENT MARKET,BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 5 GLOBAL PLANTAR FASCIITIS TREATMENT MARKET,BY END-USER, 2018-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: PLANTAR FASCIITIS TREATMENT MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 7 NORTH AMERICA: PLANTAR FASCIITIS TREATMENT MARKET,BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: PLANTAR FASCIITIS TREATMENT MARKET,BY END-USER, 2018-2032 (USD BILLION)
TABLE 9 US: PLANTAR FASCIITIS TREATMENT MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 10 US: PLANTAR FASCIITIS TREATMENT MARKET,BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 11 US: PLANTAR FASCIITIS TREATMENT MARKET,BY END-USER, 2018-2032 (USD BILLION)
TABLE 12 CANADA: PLANTAR FASCIITIS TREATMENT MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 13 CANADA: PLANTAR FASCIITIS TREATMENT MARKET,BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 14 CANADA: PLANTAR FASCIITIS TREATMENT MARKET,BY END-USER, 2018-2032 (USD BILLION)
TABLE 1 EUROPE: PLANTAR FASCIITIS TREATMENT MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 2 EUROPE: PLANTAR FASCIITIS TREATMENT MARKET, BY TREATMENT TYPE , 2018-2032 (USD BILLION)
TABLE 3 EUROPE: PLANTAR FASCIITIS TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 4 GERMANY: PLANTAR FASCIITIS TREATMENT MARKET,BY TYPE,2018-2032 (USD BILLION)
TABLE 5 GERMANY: PLANTAR FASCIITIS TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 6 GERMANY: PLANTAR FASCIITIS TREATMENT MARKET, BY END-USER , 2018-2032 (USD BILLION)
TABLE 7 FRANCE: PLANTAR FASCIITIS TREATMENT MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 8 FRANCE: PLANTAR FASCIITIS TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 9 FRANCE: PLANTAR FASCIITIS TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 10 ITALY: PLANTAR FASCIITIS TREATMENT MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 11 ITALY: PLANTAR FASCIITIS TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 12 ITALY: PLANTAR FASCIITIS TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 13 SPAIN: PLANTAR FASCIITIS TREATMENT MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 14 SPAIN: PLANTAR FASCIITIS TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 15 SPAIN: PLANTAR FASCIITIS TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 16 UK: PLANTAR FASCIITIS TREATMENT MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 17 UK: PLANTAR FASCIITIS TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 18 UK: PLANTAR FASCIITIS TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 19 REST OF EUROPE: PLANTAR FASCIITIS TREATMENT MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 20 REST OF EUROPE: PLANTAR FASCIITIS TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 21 REST OF EUROPE: PLANTAR FASCIITIS TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 22 ASIA-PACIFIC: PLANTAR FASCIITIS TREATMENT MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 23 ASIA-PACIFIC: PLANTAR FASCIITIS TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 24 ASIA-PACIFIC: PLANTAR FASCIITIS TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 25 JAPAN: PLANTAR FASCIITIS TREATMENT MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 26 JAPAN: PLANTAR FASCIITIS TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 27 JAPAN: PLANTAR FASCIITIS TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 28 CHINA: PLANTAR FASCIITIS TREATMENT MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 29 CHINA: PLANTAR FASCIITIS TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 30 CHINA: PLANTAR FASCIITIS TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 31 INDIA: PLANTAR FASCIITIS TREATMENT MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 32 INDIA: PLANTAR FASCIITIS TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 33 INDIA: PLANTAR FASCIITIS TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 34 AUSTRALIA: PLANTAR FASCIITIS TREATMENT MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 35 AUSTRALIA: PLANTAR FASCIITIS TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 36 AUSTRALIA: PLANTAR FASCIITIS TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 37 SOUTH KOREA: PLANTAR FASCIITIS TREATMENT MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 38 SOUTH KOREA: PLANTAR FASCIITIS TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 39 SOUTH KOREA: PLANTAR FASCIITIS TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 40 REST OF ASIA-PACIFIC: PLANTAR FASCIITIS TREATMENT MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 41 REST OF ASIA-PACIFIC: PLANTAR FASCIITIS TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 42 REST OF ASIA-PACIFIC: PLANTAR FASCIITIS TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 43 REST OF THE WORLD: PLANTAR FASCIITIS TREATMENT MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 44 REST OF THE WORLD: PLANTAR FASCIITIS TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 45 REST OF THE WORLD: PLANTAR FASCIITIS TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 46 MIDDLE EAST: PLANTAR FASCIITIS TREATMENT MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 47 MIDDLE EAST: PLANTAR FASCIITIS TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 48 MIDDLE EAST: PLANTAR FASCIITIS TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 49 AFRICA: PLANTAR FASCIITIS TREATMENT MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 50 AFRICA: PLANTAR FASCIITIS TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 51 AFRICA: PLANTAR FASCIITIS TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
TABLE 52 LATIN AMERICA: PLANTAR FASCIITIS TREATMENT MARKET,BY TYPE, 2018-2032 (USD BILLION)
TABLE 53 LATIN AMERICA: PLANTAR FASCIITIS TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD BILLION)
TABLE 54 LATIN AMERICA: PLANTAR FASCIITIS TREATMENT MARKET, BY END-USER, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL PLANTAR FASCIITIS TREATMENT MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL PLANTAR FASCIITIS TREATMENT MARKET
FIGURE 4 GLOBAL PLANTAR FASCIITIS TREATMENT MARKET, SHARE (%), BY TYPE, 2022
FIGURE 5 GLOBAL PLANTAR FASCIITIS TREATMENT MARKET, SHARE (%), BY TREATMENT TYPE, 2022
FIGURE 6 GLOBAL PLANTAR FASCIITIS TREATMENT MARKET, SHARE (%), BY END-USER, 2022
FIGURE 7 GLOBAL PLANTAR FASCIITIS TREATMENT MARKET, SHARE (%), BY REGION, 2022
FIGURE 8 NORTH AMERICA: PLANTAR FASCIITIS TREATMENT MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 EUROPE: PLANTAR FASCIITIS TREATMENT MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 ASIA-PACIFIC: PLANTAR FASCIITIS TREATMENT MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 REST OF THE WORLD: PLANTAR FASCIITIS TREATMENT MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 GLOBAL PLANTAR FASCIITIS TREATMENT MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 13 BAYER AG (GERMANY): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 BAYER AG (GERMANY): SWOT ANALYSIS
FIGURE 15 SUPERFEET WORLDWIDE, LLC (U.S.).:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 SUPERFEET WORLDWIDE, LLC (U.S.).:SWOT ANALYSIS
FIGURE 17 BAUERFEIND USA INC. (GERMANY):FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 BAUERFEIND USA INC. (GERMANY):SWOT ANALYSIS
FIGURE 19 OTTOBOCK (GERMANY).: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 OTTOBOCK (GERMANY).:SWOT ANALYSIS
FIGURE 21 RECOVER SPORTS MEDICINE (AUSTRALIA)..:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 RECOVER SPORTS MEDICINE (AUSTRALIA)..:SWOT ANALYSIS
FIGURE 23 SHAPECRUNCH (INDIA).:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 SHAPECRUNCH (INDIA).:SWOT ANALYSIS
FIGURE 25 3M (U.S.): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 3M (U.S.): SWOT ANALYSIS
FIGURE 27 ORTHOBETHESDA (U.S.): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 ORTHOBETHESDA (U.S.): SWOT ANALYSIS
FIGURE 29 APOTHECARY PRODUCTS, LLC (U.S.).: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 APOTHECARY PRODUCTS, LLC (U.S.).: SWOT ANALYSIS
FIGURE 31 ELLIS & BADENHAUSEN (U.S.).:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 ELLIS & BADENHAUSEN (U.S.).:SWOT ANALYSIS
FIGURE 33 SYNXSOLE PTY LTD. (AUSTRALIA): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 SYNXSOLE PTY LTD. (AUSTRALIA): SWOT ANALYSIS
FIGURE 35 REVANCE THERAPEUTICS, (U.S.):FINANCIAL OVERVIEW SNAPSHOT
FIGURE 36 REVANCE THERAPEUTICS, (U.S.):SWOT ANALYSIS
